- Home
- MRNA vs ZBH Comparison
MRNA vs ZBH Comparison
Compare MRNA & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | ZBH |
|---|---|---|
| Founded | 2010 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5B | 19.5B |
| IPO Year | 2018 | 2001 |
Fundamental Metrics
Financial Performance| Metric | MRNA | ZBH |
|---|---|---|
| Price | $45.90 | $82.23 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 12 | 21 |
| Target Price | $34.27 | ★ $101.00 |
| AVG Volume (30 Days) | ★ 4.9M | 2.4M |
| Earning Date | 05-01-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.20% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ 3.55 |
| Revenue | ★ $19,263,000,000.00 | $8,231,500,000.00 |
| Revenue This Year | $9.36 | $4.96 |
| Revenue Next Year | $15.43 | $3.76 |
| P/E Ratio | ★ N/A | $23.12 |
| Revenue Growth | 4.29 | ★ 7.20 |
| 52 Week Low | $22.28 | $79.83 |
| 52 Week High | $59.55 | $108.29 |
Technical Indicators
Market Signals| Indicator | MRNA | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 36.20 | 31.69 |
| Support Level | $23.52 | N/A |
| Resistance Level | $55.36 | $96.94 |
| Average True Range (ATR) | 2.71 | 2.82 |
| MACD | -0.94 | -1.44 |
| Stochastic Oscillator | 12.35 | 13.69 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.